Beijing-based oncology research and development firm BeiGene (Beijing) Co., Ltd., backed by Hillhouse Capital and CITIC Private Equity, has filed for an initial public offering in the U.S., according to a securities filing. The prospectus did not reveal any financial details of the offering yet, but it is disclosed that Hilhouse Capital owns 9.9% and […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.